Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF and autologous bone marrow progenitor cell infusion for ischemic heart failure
2005-002706-27Phase 2Completed
- Sponsor
- Barts Health NHS Trust
- Start
- Jun 2005
- Modality
- Stem Cell Therapies → Cell Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of autologous bone marrow-derived mononuclear cell and granulocyte colony-stimulating factor in heart failure (HF) (2 arms), sponsored by Barts Health NHS Trust. Primary endpoints: Change in global left ventricular ejection fraction, Change in regional wall motion score index and 1 more. Started Jun 2005; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cellgranulocyte colony-stimulating factor
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2005-002706-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002706-27.